TNFSF11 and osteoporosis: OPG acts as a decoy receptor for RANKL and inhibit osteoclastogenesis, and a downregulation in OPG (observed in MONA patients) is associated with increased osteoporosis (Bucay et al., 1998; Takayanagi, 2007; Mori et al., 2013).